Key Decisions Approved

The Board of Directors of Aster DM Quality Care Limited at its meeting held on 05 August 2026 (commencing at 02:30 PM IST and concluding at 04:40 PM IST) approved the following matters:

1. Shareholder Approval Process: Approval to seek shareholder approval for special business through Postal Ballot. The Notice of Postal Ballot will be sent to shareholders and stock exchanges in due course.

2. Annual General Meeting: Convening of the 18th Annual General Meeting of the Company on Monday, 28 September 2026, at 11:30 A.M. IST through video conferencing or other audio-video means. The notice will be sent to shareholders and stock exchanges in due course.

3. Termination of Hospital Agreement: Termination of the operations and management agreement in respect of Aster G. Madegowda Hospital, Maddur.

4. Subsidiary Share Acquisition: Acquisition of equity shares of United CIIGMA Institute of Medical Sciences Private Limited (UCIMSPL), an existing subsidiary company, pursuant to the exercise of put option rights by certain minority shareholders under the Shareholders' Agreement.

Detailed Breakdown of Decisions

Termination of Aster G. Madegowda Hospital Agreement
  • Binding Agreement Date: 1 April 2023
  • Financial Impact: The hospital contributed 0.15% of the entity's revenue during the last financial year.
  • Closure Date: 5 August 2026 (or such effective date as may be finalized between the parties)
  • Reasons for Closure: The hospital has not achieved the anticipated operational scale and profitability and has incurred sustained operating losses since commencement of operations. Following a strategic review, the Company decided to discontinue the arrangement and exit the facility.
Acquisition of United CIIGMA Institute of Medical Sciences (UCIMSPL) Shares
  • Target Entity: United CIIGMA Institute of Medical Sciences Private Limited
  • Incorporation Date: 7 February 2011
  • Authorized Share Capital: Rs. 52,00,00,000 (Rupees Fifty-Two Crore Only) comprising 5,20,00,000 equity shares of face value Rs. 10/- each
  • Paid-up Share Capital: Rs. 51,36,67,110 (Rupees Fifty-one crore thirty-six lakhs sixty-seven thousand one hundred and ten Only) comprising 5,13,66,711 equity shares of face value Rs. 10/- each
  • Turnover (FY ended 31 March 2026): Rs. 153.64 crores
  • Industry: Healthcare Industry
  • Transaction Nature: Acquisition of up to an additional 12% equity stake through exercise of put option by the Promoter/Promoter Group of UCIMSPL, in accordance with the Shareholders' Agreement dated June 10, 2022
  • Regulatory Approvals: Not Applicable
  • Completion Timeline: Within the next 1–2 months
  • Consideration Type: Cash consideration
  • Acquisition Cost: Up to Rs. 40.93 crores
  • Percentage Acquired: Up to 12%
  • Post-Acquisition Status: UCIMSPL will continue to be the Acquirer's Subsidiary
  • Transaction Basis: Arm's length basis
  • Entity Background: UCIMSPL is headquartered in Chhatrapati Sambhajinagar and is primarily engaged in providing healthcare and related services.

Additional Information

  • The information will be hosted on the company website: www.asterqualitycare.com
  • The disclosure is made in accordance with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
  • Signed by Hemish Purushottam, Company Secretary and Compliance Officer (M. No: A24331)